Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29785

1.

Epidemiology in ovarian carcinoma: lessons from autopsy.

Güth U, Arndt V, Stadlmann S, Huang DJ, Singer G.

Gynecol Oncol. 2015 May 21. pii: S0090-8258(15)00921-X. doi: 10.1016/j.ygyno.2015.05.013. [Epub ahead of print]

PMID:
26005053
2.

Spectrum of ovarian tumors: Histopathological study of 218 cases.

Mansoor NA, Jezan HS.

Gulf J Oncolog. 2015 May;1(18):64-70.

PMID:
26003107
3.

The Significance of Paracardiac Lymph-Node Enlargement In Patients With Newly Diagnosed Stage IIIC Ovarian Cancer.

Raban O, Peled Y, Krissi H, Goldberg N, Aviram A, Sabah G, Levavi H, Eitan R.

Gynecol Oncol. 2015 May 19. pii: S0090-8258(15)00912-9. doi: 10.1016/j.ygyno.2015.05.007. [Epub ahead of print]

PMID:
26001327
4.

Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas.

Wang A, Guo C, Sun Y, Lu L, Wang Y, Wang Q, Zhang Y, Zhang H, Wang L, Gu Y, Liu A.

J Cancer. 2015 Apr 29;6(6):542-7. doi: 10.7150/jca.11420. eCollection 2015.

5.

Potential new chemotherapy strategy for human ovarian carcinoma with a novel KSP inhibitor.

Takenaga M, Yamamoto Y, Takeuchi T, Ohta Y, Tokura Y, Hamaguchi A, Asai D, Nakashima H, Oishi S, Fujii N.

Biochem Biophys Res Commun. 2015 May 19. pii: S0006-291X(15)00943-2. doi: 10.1016/j.bbrc.2015.05.029. [Epub ahead of print]

PMID:
25998394
6.

Sp1-CD147 positive feedback loop promotes the invasion ability of ovarian cancer.

Zhao J, Ye W, Wu J, Liu L, Yang L, Gao L, Chen B, Zhang F, Yang H, Li Y.

Oncol Rep. 2015 May 20. doi: 10.3892/or.2015.3999. [Epub ahead of print]

PMID:
25998266
7.

Ovarian Small Cell Carcinoma of Pulmonary Type Arising in Mature Cystic Teratomas With Metastases to the Contralateral Ovary.

Rubio A, Schuldt M, Chamorro C, Crespo-Lora V, Nogales FF.

Int J Surg Pathol. 2015 May 19. pii: 1066896915586254. [Epub ahead of print]

PMID:
25990936
8.

Benefits of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography in Secondary Cytoreductive Surgery for Patients with Recurrent Epithelial Ovarian Cancer.

Peng P, Zhu Z, Zhong Z, Zheng K, Yang J, Cao D, Shen K.

Br J Radiol. 2015 May 20:20150109. [Epub ahead of print]

PMID:
25989698
9.

The G-protein coupled receptor 55-agonist L-α-lysophosphatidylinositol mediates ovarian carcinoma cell induced angiogenesis.

Hofmann NA, Yang J, Trauger SA, Nakayama H, Huang L, Strunk D, Moses MA, Klagsbrun M, Bischoff J, Graier WF.

Br J Pharmacol. 2015 May 18. doi: 10.1111/bph.13196. [Epub ahead of print]

PMID:
25989290
10.

Biobehavioral and neuroendocrine correlates of antioxidant enzyme activity in ovarian carcinoma.

Bayer JL, Spitz DR, Christensen D, McCormick ML, Farley D, DeGeest K, Damoush L, Aust S, Sood AK, Lutgendorf SK.

Brain Behav Immun. 2015 May 16. pii: S0889-1591(15)00127-0. doi: 10.1016/j.bbi.2015.04.019. [Epub ahead of print]

PMID:
25989110
11.

Enhancing survival with early surgical resection of endobronchial metastasis in a follow-up of ovarian carcinoma.

Franco RM, Guimaraes MD, Moreira BL, Bitencourt AG, Hochhegger B, Marchiori E.

Radiol Bras. 2015 Mar-Apr;48(2):130. doi: 10.1590/0100-3984.2013.0020. No abstract available.

12.

Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.

Mackenzie R, Kommoss S, Winterhoff BJ, Kipp BR, Garcia JJ, Voss J, Halling K, Karnezis A, Senz J, Yang W, Prigge ES, Reuschenbach M, Doeberitz MV, Gilks BC, Huntsman DG, Bakkum-Gamez J, McAlpine JN, Anglesio MS.

BMC Cancer. 2015 May 19;15(1):415.

13.

The role of Cyclin G1 in cellular proliferation and apoptosis of human epithelial ovarian cancer.

Jiang L, Liu R, Wang Y, Li C, Xi Q, Zhong J, Liu J, Yang S, Wang J, Huang M, Tang C, Fang Z.

J Mol Histol. 2015 May 17. [Epub ahead of print]

PMID:
25981880
14.

Survival of Patients With Mucinous Ovarian Carcinoma and Ovarian Metastases: A Population-Based Cancer Registry Study.

Simons M, Ezendam N, Bulten J, Nagtegaal I, Massuger L.

Int J Gynecol Cancer. 2015 May 14. [Epub ahead of print]

PMID:
25978291
15.

Rapamycin enhanced the antitumor efficacy of oxaliplatin in cisplatin-resistant ovarian cancer cells A2780cis both in vitro and in vivo.

Liu J, Zhang L, Zhang X, Xing X.

J Chemother. 2015 May 15:1973947815Y0000000021. [Epub ahead of print]

PMID:
25976336
16.

[Screening of citrullinated proteins in ten tumor cell lines].

Zhang W, Ma L, Sui Y, Chang X.

Zhonghua Zhong Liu Za Zhi. 2015 Mar;37(3):165-9. Chinese.

PMID:
25975782
17.
18.

Inhibition of ovarian cancer proliferation and invasion by pachymic acid.

Gao AH, Zhang L, Chen X, Chen Y, Xu ZZ, Liu YN, Zhang H.

Int J Clin Exp Pathol. 2015 Feb 1;8(2):2235-41. eCollection 2015.

19.

Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium.

Iwamoto M, Nakatani Y, Fugo K, Kishimoto T, Kiyokawa T.

Hum Pathol. 2015 Apr 11. pii: S0046-8177(15)00109-4. doi: 10.1016/j.humpath.2015.03.008. [Epub ahead of print]

PMID:
25971546
20.

Tumorigenesis and peritoneal colonization from fallopian tube epithelium.

Eddie SL, Quartuccio SM, hAinmhire EÓ, Moyle-Heyrman G, Lantvit DD, Wei JJ, Vanderhyden BC, Burdette JE.

Oncotarget. 2015 May 4. [Epub ahead of print]

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk